Colistin-Link New Zealand - English - Medsafe (Medicines Safety Authority)

colistin-link

link pharmaceuticals ltd - colistimethate sodium 384.6 mg/ml - powder for injection - 150 mg/2ml - active: colistimethate sodium 384.6 mg/ml - the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli; particularly when the infection is caused by sensitive strains of pseudomonas aeruginosa, and the following gram-negative organisms; aerobacter aerogenes, escherichia coli, klebsiella pneumoniae. pending results of appropriate bacteriologic cultures and sensitivity tests, colistimethate sodium may be used to initiate therapy in serious infections that are suspected to be due to gram-negative organisms.

COLISTIN LINK colistimethate sodium (equivalent to colistin 150 mg, 4,500,000 IU)  powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

colistin link colistimethate sodium (equivalent to colistin 150 mg, 4,500,000 iu) powder for injection vial

link medical products pty ltd t/a link pharmaceuticals - colistimethate sodium (equivalent: colistin, qty iu) - injection, powder for - excipient ingredients: - colistin link parental is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. it is particularly indicated when the infection is caused by sensitve strains of pseudomonas aeruginosa. this antibiotic is not indicated for infections due to proteus and neisseria. colistin link parental has proven clinically effective in treatment of infections due to the following gram-negative organisms: enterobacter aerogenes, escherichia coli, klebsiella pneumoniae and pseudomonas aeruginosa. pending results of appropriate bacterialogic cultures and sensitvity tests, colistin link parental may be used to initiate therapy in serious infections that are suspected due to gram-negative organisms.

Chloramphenicol LINK New Zealand - English - Medsafe (Medicines Safety Authority)

chloramphenicol link

link pharmaceuticals ltd - chloramphenicol sodium succinate 1.4 g equivalent to chloramphenicol 1 g - powder for injection - 1 g - active: chloramphenicol sodium succinate 1.4 g equivalent to chloramphenicol 1 g - chloramphenicol succinate is specifically indicated for bacterial meningitis, typhoid fever, rickettsial infections, intraocular infections and other serious infections where bacteriological evidence or clinical judgement indicates that chloramphenicol is an appropriate antibiotic.

Dapsone (Link) New Zealand - English - Medsafe (Medicines Safety Authority)

dapsone (link)

link pharmaceuticals ltd - dapsone 100mg - tablet - 100 mg - active: dapsone 100mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - dermatitis herpetiformis.

Dapsone (Link) New Zealand - English - Medsafe (Medicines Safety Authority)

dapsone (link)

link pharmaceuticals ltd - dapsone 25mg - tablet - 25 mg - active: dapsone 25mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - dermatitis herpetiformis.

ADRENALINE-LINK 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP pre filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

adrenaline-link 1:10,000 1mg/10ml adrenaline (epinephrine) acid tartrate injection bp pre filled syringe

link medical products pty ltd t/a link pharmaceuticals - adrenaline (epinephrine) acid tartrate, quantity: 182 microgram/ml (equivalent: adrenaline (epinephrine), qty 100 microgram/ml) - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium metabisulfite; dilute hydrochloric acid; water for injections; sodium chloride; citric acid monohydrate - adrenaline 1:10,000 is used as an adjunct in the management of cardiac arrest.

ADRENALINE-LINK 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

adrenaline-link 1:10,000 1mg/10ml adrenaline (epinephrine) acid tartrate injection bp ampoule

link medical products pty ltd t/a link pharmaceuticals - adrenaline (epinephrine) acid tartrate, quantity: 182 microgram/ml (equivalent: adrenaline (epinephrine), qty 100 microgram/ml) - injection, solution - excipient ingredients: citric acid monohydrate; sodium metabisulfite; sodium chloride; sodium citrate dihydrate; water for injections; dilute hydrochloric acid - adrenaline 1:10,000 is used as an adjunct in the management of cardiac arrest.

MERCAPTOPURINE-LINK mercaptopurine monohydrate 50 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

mercaptopurine-link mercaptopurine monohydrate 50 mg tablet bottle

link medical products pty ltd t/a link pharmaceuticals - mercaptopurine monohydrate, quantity: 50 mg - tablet - excipient ingredients: pregelatinised maize starch; stearic acid; maize starch; magnesium stearate; lactose - treatment of acute leukaemia. it is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukaemia and acute myelogenous leukaemia.,mercaptopurine-link is also used in the treatment of chronic granulocytic leukaemia.

ADRENALINE-LINK 1:1,000 1mg/1mL adrenaline (epinephrine) acid tartrate injection BP ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

adrenaline-link 1:1,000 1mg/1ml adrenaline (epinephrine) acid tartrate injection bp ampoule

link medical products pty ltd t/a link pharmaceuticals - adrenaline (epinephrine) acid tartrate, quantity: 1.82 mg/ml (equivalent: adrenaline (epinephrine), qty 1 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; hydrochloric acid; sodium hydroxide; water for injections - indications as at 27 june 2003: adrenaline 1:1,000 is the drug of choice in the emergency treatment of acute severe anaphylactic reactions due to insect bites, drugs and other allergens. it may also be used for the symptomatic relief of respiratory distress due to bronchospasm.

Vepesid New Zealand - English - Medsafe (Medicines Safety Authority)

vepesid

link pharmaceuticals ltd - etoposide 100mg - capsule - 100 mg - active: etoposide 100mg excipient: citric acid monohydrate gelatin glycerol   iron oxide red macrogol 400 propyl hydroxybenzoate sodium ethyl hydroxybenzoate titanium dioxide water